CETIRIZINE HCL

CETIRIZINE HCL was reported 9080 times

CETIRIZINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPURA SENILE 7 0.0574
1 DEVICE WIRELESS COMMUNICATION ISSUE 9 0.0347
2 TARSAL TUNNEL SYNDROME 6 0.0273
3 PATIENT DISSATISFACTION WITH DEVICE 6 0.0238
4 INFUSION SITE DISCHARGE 36 0.0205
5 DEVICE MAINTENANCE ISSUE 12 0.0204
6 INJECTION SITE BURNING 12 0.0154
7 INFUSION SITE MASS 16 0.0147
8 INFUSION SITE HAEMORRHAGE 40 0.0121
9 INFUSION SITE IRRITATION 14 0.0109
10 DEVICE INFUSION ISSUE 26 0.0105
11 INFUSION SITE INDURATION 15 0.0101
12 INFUSION SITE INFECTION 22 0.0095
13 INFUSION SITE SWELLING 57 0.0090
14 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13 0.0089
15 INFUSION SITE WARMTH 10 0.0082
16 INFUSION SITE ERYTHEMA 68 0.0081
17 SEASONAL ALLERGY 109 0.0077
18 INFUSION SITE PRURITUS 24 0.0076
19 INFUSION SITE PAIN 97 0.0075
20 SKIN TEST POSITIVE 7 0.0075
21 INFUSION SITE BRUISING 16 0.0074
22 EYELID PAIN 15 0.0074
23 RESORPTION BONE INCREASED 6 0.0073
24 INFUSION SITE NODULE 7 0.0073
25 MAST CELL ACTIVATION SYNDROME 10 0.0071
26 PERIORBITAL PAIN 6 0.0071
27 CATAPLEXY 10 0.0071
28 ENDOCRINE OPHTHALMOPATHY 6 0.0069
29 MULTIPLE ALLERGIES 54 0.0069
30 PRODUCT ADMINISTRATION INTERRUPTED 54 0.0069
31 VESTIBULAR DISORDER 8 0.0065
32 NASAL DISCHARGE DISCOLOURATION 9 0.0065
33 CATHETER SITE SWELLING 6 0.0064
34 ARNOLD-CHIARI MALFORMATION 6 0.0063
35 HYDROCELE 6 0.0056
36 DEVICE ALARM ISSUE 10 0.0055
37 ARRHYTHMIA SUPRAVENTRICULAR 6 0.0055
38 PRE-EXISTING CONDITION IMPROVED 31 0.0050
39 NOROVIRUS INFECTION 7 0.0048
40 ILLUSION 8 0.0048
41 DEVICE POWER SOURCE ISSUE 14 0.0048
42 VERTIGO POSITIONAL 8 0.0046
43 NASAL DISORDER 12 0.0045
44 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
45 INFUSION SITE REACTION 13 0.0043
46 PULMONARY ARTERIAL PRESSURE INCREASED 7 0.0043
47 THERAPEUTIC PROCEDURE 6 0.0043
48 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.0042
49 DERMATITIS CONTACT 47 0.0041
50 RHINOVIRUS INFECTION 16 0.0041
51 EYE CONTUSION 8 0.0038
52 MATERNAL DRUGS AFFECTING FOETUS 29 0.0038
53 INCORRECT DRUG ADMINISTRATION RATE 16 0.0038
54 MULTIPLE DRUG OVERDOSE INTENTIONAL 12 0.0037
55 MIDDLE EAR EFFUSION 8 0.0036
56 HEPATORENAL SYNDROME 6 0.0036
57 INSURANCE ISSUE 53 0.0035
58 HEPATITIS TOXIC 9 0.0035
59 ESSENTIAL HYPERTENSION 6 0.0033
60 SCRATCH 34 0.0032
61 PARANASAL SINUS DISCOMFORT 12 0.0032
62 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
63 SINUS PAIN 7 0.0030
64 ANGIONEUROTIC OEDEMA 8 0.0030
65 RHINITIS ALLERGIC 13 0.0029
66 RED BLOOD CELL COUNT INCREASED 8 0.0029
67 HYPOSPADIAS 6 0.0029
68 DEVICE CONNECTION ISSUE 6 0.0028
69 HYPERPHAGIA 11 0.0028
70 EAR INFECTION 73 0.0027
71 BLEPHARITIS 11 0.0027
72 SLEEP APNOEA SYNDROME 52 0.0027
73 SINUS DISORDER 53 0.0027
74 THROMBOPHLEBITIS SUPERFICIAL 8 0.0026
75 HYPERVOLAEMIA 13 0.0026
76 PARANASAL SINUS HYPERSECRETION 10 0.0026
77 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
78 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
79 SKIN WEEPING 9 0.0025
80 DRUG TOLERANCE DECREASED 7 0.0025
81 ENURESIS 10 0.0025
82 OXYGEN SATURATION ABNORMAL 7 0.0025
83 HAEMATOLOGICAL INFECTION 6 0.0025
84 SKIN SWELLING 21 0.0024
85 HAEMOGLOBIN INCREASED 11 0.0024
86 GASTROINTESTINAL NECROSIS 7 0.0024
87 SNORING 9 0.0024
88 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
89 BLOOD CHLORIDE DECREASED 6 0.0023
90 VIRAL INFECTION 77 0.0023
91 SKIN HAEMORRHAGE 34 0.0023
92 PRODUCTIVE COUGH 109 0.0023
93 ONYCHOMYCOSIS 10 0.0023
94 RADICULOPATHY 6 0.0023
95 RESPIRATORY TRACT INFECTION 59 0.0023
96 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
97 SINUSITIS 228 0.0022
98 GAMBLING DISORDER 6 0.0022
99 RESPIRATORY TRACT CONGESTION 35 0.0022
100 UPPER RESPIRATORY TRACT INFECTION 101 0.0022
101 CYSTIC FIBROSIS 12 0.0022
102 EOSINOPHILIC OESOPHAGITIS 6 0.0022
103 DERMATITIS ATOPIC 114 0.0022
104 GASTROENTERITIS VIRAL 39 0.0022
105 NEURODERMATITIS 8 0.0021
106 PRODUCT LEAKAGE 12 0.0021
107 DEAFNESS NEUROSENSORY 7 0.0021
108 LIGAMENT SPRAIN 21 0.0021
109 CYTOLYTIC HEPATITIS 7 0.0021
110 SCOLIOSIS 13 0.0021
111 GASTRIC INFECTION 8 0.0021
112 CHOLECYSTITIS CHRONIC 14 0.0021
113 THYROID MASS 8 0.0021
114 FIBULA FRACTURE 6 0.0021
115 HORDEOLUM 9 0.0021
116 ADENOVIRUS INFECTION 6 0.0021
117 HEREDITARY ANGIOEDEMA 22 0.0020
118 INJECTION SITE DISCHARGE 11 0.0020
119 PHARYNGEAL SWELLING 20 0.0020
120 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11 0.0020
121 OBSTRUCTION 8 0.0020
122 VEIN DISORDER 10 0.0020
123 SECRETION DISCHARGE 25 0.0020
124 HANGOVER 7 0.0020
125 SOMNAMBULISM 13 0.0020
126 INTERVERTEBRAL DISC DEGENERATION 18 0.0019
127 SENSITIVE SKIN 14 0.0019
128 FOREIGN BODY SENSATION IN EYES 12 0.0019
129 INTERVERTEBRAL DISC DISORDER 8 0.0019
130 PRODUCT DOSE OMISSION IN ERROR 53 0.0019
131 PULMONARY FUNCTION TEST DECREASED 8 0.0018
132 BREATH SOUNDS ABNORMAL 9 0.0018
133 WEIGHT FLUCTUATION 19 0.0018
134 ASTHMA 203 0.0018
135 SPUTUM DISCOLOURED 17 0.0018
136 POST-TRAUMATIC STRESS DISORDER 12 0.0018
137 PLANTAR FASCIITIS 6 0.0018
138 BRAIN FOG 28 0.0018
139 RESPIRATORY ACIDOSIS 7 0.0018
140 SINUS CONGESTION 24 0.0018
141 DRUG EXPOSURE DURING PREGNANCY 60 0.0018
142 DECREASED ACTIVITY 19 0.0018
143 PHARYNGITIS STREPTOCOCCAL 19 0.0018
144 BIPOLAR DISORDER 19 0.0017
145 RESPIRATION ABNORMAL 12 0.0017
146 SNEEZING 39 0.0017
147 TACHYPHRENIA 6 0.0017
148 ARTHRITIS INFECTIVE 8 0.0017
149 FLANK PAIN 16 0.0017
150 FACIAL PARESIS 6 0.0017
151 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
152 SKIN FISSURES 33 0.0017
153 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
154 ECZEMA 87 0.0017
155 PURULENT DISCHARGE 7 0.0016
156 SHOULDER OPERATION 7 0.0016
157 RASH MACULAR 57 0.0016
158 ATRIAL FLUTTER 13 0.0016
159 NERVE COMPRESSION 15 0.0016
160 HOSPICE CARE 16 0.0016
161 ARTHROPOD BITE 12 0.0016
162 FOOT OPERATION 8 0.0016
163 MULTIPLE DRUG OVERDOSE 8 0.0016
164 INFUSION SITE EXTRAVASATION 10 0.0016
165 PROTEIN TOTAL DECREASED 6 0.0016
166 BLEPHAROSPASM 10 0.0016
167 CATHETERISATION CARDIAC 7 0.0016
168 INITIAL INSOMNIA 16 0.0016
169 SKIN WARM 9 0.0015
170 VASCULAR DEVICE INFECTION 7 0.0015
171 ORAL INFECTION 6 0.0015
172 TENDERNESS 16 0.0015
173 POOR QUALITY SLEEP 33 0.0015
174 RHINORRHOEA 99 0.0015
175 OXYGEN SATURATION DECREASED 86 0.0015
176 EAR DISORDER 7 0.0015
177 FIBROMYALGIA 37 0.0015
178 PRODUCT DISTRIBUTION ISSUE 14 0.0015
179 RIB FRACTURE 31 0.0015
180 FOOD POISONING 8 0.0015
181 THROAT IRRITATION 67 0.0015
182 RHINITIS 12 0.0015
183 MYASTHENIA GRAVIS 12 0.0015
184 FEELING DRUNK 11 0.0015
185 INTENTIONAL DOSE OMISSION 42 0.0015
186 BRONCHITIS 109 0.0015
187 EYE PAIN 83 0.0015
188 JAW DISORDER 8 0.0015
189 IMPAIRED QUALITY OF LIFE 21 0.0015
190 PARAESTHESIA ORAL 21 0.0015
191 HYPERKERATOSIS 8 0.0014
192 OROPHARYNGEAL DISCOMFORT 13 0.0014
193 SWELLING OF EYELID 9 0.0014
194 ONYCHOMADESIS 6 0.0014
195 ILLNESS 147 0.0014
196 SLEEP TERROR 6 0.0014
197 EYE INFECTION 16 0.0014
198 COUGH 396 0.0014
199 FUNGAL INFECTION 47 0.0014
200 RETCHING 30 0.0014
201 PROTEIN URINE PRESENT 7 0.0014
202 TEARFULNESS 6 0.0014
203 CARDIAC FLUTTER 9 0.0014
204 HEPATITIS ACUTE 9 0.0014
205 DYSPNOEA EXERTIONAL 52 0.0014
206 HYPERVENTILATION 8 0.0014
207 TOOTH ABSCESS 14 0.0014
208 POLYP 9 0.0014
209 FEMORAL NECK FRACTURE 7 0.0014
210 TOOTH INFECTION 18 0.0014
211 EAR DISCOMFORT 14 0.0014
212 LIMB INJURY 37 0.0014
213 APHONIA 19 0.0014
214 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
215 APPETITE DISORDER 9 0.0014
216 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
217 IRRITABLE BOWEL SYNDROME 29 0.0014
218 CONJUNCTIVITIS 25 0.0013
219 ODYNOPHAGIA 8 0.0013
220 ACCIDENTAL OVERDOSE 49 0.0013
221 SENSITIVITY TO WEATHER CHANGE 7 0.0013
222 COELIAC DISEASE 13 0.0013
223 INJECTION SITE VESICLES 8 0.0013
224 IMPAIRED GASTRIC EMPTYING 18 0.0013
225 PRODUCT DOSE OMISSION ISSUE 387 0.0013
226 DROOLING 9 0.0013
227 POST PROCEDURAL COMPLICATION 25 0.0013
228 LYMPHOEDEMA 9 0.0013
229 MENISCUS INJURY 8 0.0013
230 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
231 STRESS FRACTURE 7 0.0013
232 ROSACEA 6 0.0013
233 NEPHROLITHIASIS 59 0.0013
234 DEVICE OCCLUSION 18 0.0013
235 DRY THROAT 13 0.0013
236 NASAL DRYNESS 8 0.0013
237 BLOOD SODIUM DECREASED 24 0.0013
238 CHOKING SENSATION 7 0.0013
239 FEAR OF INJECTION 9 0.0013
240 PRODUCT SUPPLY ISSUE 9 0.0013
241 ENDOMETRIOSIS 6 0.0013
242 STREPTOCOCCAL INFECTION 7 0.0013
243 SPINAL OSTEOARTHRITIS 11 0.0013
244 OCULAR DISCOMFORT 14 0.0012
245 PANIC REACTION 9 0.0012
246 FRUSTRATION TOLERANCE DECREASED 10 0.0012
247 FACIAL PAIN 11 0.0012
248 AUTOIMMUNE DISORDER 12 0.0012
249 GASTROINTESTINAL INFECTION 11 0.0012
250 GOUT 22 0.0012
251 DRY EYE 61 0.0012
252 EYE PRURITUS 41 0.0012
253 SPINAL OPERATION 15 0.0012
254 SMALL FOR DATES BABY 6 0.0012
255 NASAL CONGESTION 71 0.0012
256 THERAPEUTIC RESPONSE SHORTENED 40 0.0012
257 VASCULITIS 14 0.0012
258 OEDEMA 65 0.0012
259 PNEUMONIA BACTERIAL 11 0.0012
260 IRON DEFICIENCY ANAEMIA 11 0.0012
261 LACRIMATION INCREASED 36 0.0012
262 BREAST MASS 8 0.0012
263 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
264 ECONOMIC PROBLEM 18 0.0012
265 BRONCHIECTASIS 8 0.0012
266 HAEMOPTYSIS 33 0.0012
267 EYE SWELLING 44 0.0012
268 ULCER HAEMORRHAGE 8 0.0012
269 BOWEL MOVEMENT IRREGULARITY 9 0.0012
270 PHLEBITIS 6 0.0012
271 VITAMIN D DECREASED 10 0.0012
272 PRURITUS 449 0.0012
273 PSEUDOMONAS INFECTION 10 0.0012
274 FOOD ALLERGY 9 0.0012
275 LIMB DISCOMFORT 36 0.0012
276 CONCUSSION 9 0.0012
277 SKIN EXFOLIATION 98 0.0012
278 RASH GENERALISED 30 0.0012
279 LOCALISED INFECTION 28 0.0012
280 EYE DISCHARGE 12 0.0012
281 PLATELET COUNT INCREASED 15 0.0011
282 INFLUENZA 128 0.0011
283 TORSADE DE POINTES 9 0.0011
284 CARPAL TUNNEL SYNDROME 16 0.0011
285 FLUID RETENTION 58 0.0011
286 COVID-19 199 0.0011
287 WHEEZING 67 0.0011
288 PHARYNGOLARYNGEAL PAIN 6 0.0011
289 URTICARIA 189 0.0011
290 SURGERY 66 0.0011
291 BRONCHOSPASM 16 0.0011
292 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
293 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
294 THIRST 20 0.0011
295 SLEEP DISORDER 79 0.0011
296 GASTROOESOPHAGEAL REFLUX DISEASE 90 0.0011
297 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
298 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 8 0.0011
299 THROAT TIGHTNESS 30 0.0011
300 ERYTHEMA OF EYELID 6 0.0011
301 BLADDER DISORDER 11 0.0011
302 BACK DISORDER 18 0.0011
303 BACK INJURY 12 0.0011
304 CONVULSION 63 0.0011
305 FAECES SOFT 8 0.0011
306 RESTLESS LEGS SYNDROME 20 0.0011
307 BLOOD POTASSIUM DECREASED 33 0.0011
308 BLOOD IRON DECREASED 13 0.0011
309 ARTHRITIS 86 0.0011
310 TOXIC SKIN ERUPTION 11 0.0011
311 NASOPHARYNGITIS 201 0.0011
312 INCREASED TENDENCY TO BRUISE 10 0.0011
313 EAR PAIN 21 0.0011
314 EATING DISORDER 23 0.0011
315 HEART RATE ABNORMAL 6 0.0011
316 PNEUMOTHORAX 17 0.0011
317 ORAL PAIN 24 0.0011
318 BURSITIS 13 0.0011
319 INFUSION RELATED REACTION 71 0.0011
320 NOCTURIA 13 0.0011
321 RASH PRURITIC 58 0.0011
322 SKIN INFECTION 12 0.0011
323 SKIN CANCER 23 0.0011
324 FACE OEDEMA 18 0.0011
325 OBESITY 17 0.0011
326 GALLBLADDER DISORDER 19 0.0011
327 WALKING AID USER 7 0.0011
328 VENTRICULAR EXTRASYSTOLES 11 0.0011
329 PETECHIAE 11 0.0011
330 FLUSHING 107 0.0011
331 CHOLECYSTECTOMY 12 0.0010
332 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
333 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
334 BLOOD MAGNESIUM DECREASED 9 0.0010
335 MIGRAINE 99 0.0010
336 ANKLE FRACTURE 16 0.0010
337 RALES 6 0.0010
338 DIZZINESS POSTURAL 10 0.0010
339 BODY HEIGHT DECREASED 11 0.0010
340 GASTROENTERITIS 15 0.0010
341 DRUG TOXICITY 14 0.0010
342 DEVICE INFORMATION OUTPUT ISSUE 8 0.0010
343 DRY SKIN 137 0.0010
344 CHEST DISCOMFORT 105 0.0010
345 INFECTION 148 0.0010
346 NECK PAIN 57 0.0010
347 KIDNEY INFECTION 20 0.0010
348 DECREASED INTEREST 6 0.0010
349 MIDDLE INSOMNIA 19 0.0010
350 BRADYKINESIA 6 0.0010
351 PRODUCT USE COMPLAINT 16 0.0010
352 SINUS HEADACHE 6 0.0010
353 WRONG DRUG ADMINISTERED 9 0.0010
354 ANAPHYLACTIC SHOCK 26 0.0010
355 PULMONARY HYPERTENSION 21 0.0010
356 OROPHARYNGEAL PAIN 93 0.0010
357 HIATUS HERNIA 13 0.0010
358 SCIATICA 16 0.0010
359 STAPHYLOCOCCAL INFECTION 33 0.0010
360 OVARIAN CYST 10 0.0010
361 ABORTION SPONTANEOUS 40 0.0010
362 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
363 HYPOXIA 35 0.0010
364 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
365 ORAL CANDIDIASIS 13 0.0010
366 THERMAL BURN 7 0.0010
367 POST PROCEDURAL INFECTION 8 0.0010
368 HEPATITIS 25 0.0010
369 PERIPHERAL SWELLING 150 0.0010
370 ORAL HERPES 19 0.0010
371 PRURITUS GENERALISED 21 0.0010
372 TEMPERATURE INTOLERANCE 10 0.0010
373 PERSONALITY CHANGE 9 0.0010
374 PHARYNGITIS 12 0.0010
375 POOR VENOUS ACCESS 10 0.0010
376 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
377 MUSCLE INJURY 8 0.0010
378 SCAB 11 0.0010
379 RASH ERYTHEMATOUS 46 0.0010
380 BLISTER 54 0.0010
381 DRUG ERUPTION 17 0.0010
382 ATRIAL SEPTAL DEFECT 8 0.0010
383 PAIN IN JAW 27 0.0010
384 NEURALGIA 23 0.0009
385 FULL BLOOD COUNT ABNORMAL 10 0.0009
386 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
387 OSTEOARTHRITIS 40 0.0009
388 LUNG DISORDER 46 0.0009
389 ROTATOR CUFF SYNDROME 12 0.0009
390 MUSCULOSKELETAL DISCOMFORT 16 0.0009
391 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 6 0.0009
392 VITAMIN D DEFICIENCY 9 0.0009
393 MACULAR DEGENERATION 11 0.0009
394 SKIN LACERATION 10 0.0009
395 DISCOMFORT 56 0.0009
396 PRODUCT PREPARATION ISSUE 6 0.0009
397 POLLAKIURIA 38 0.0009
398 GROIN PAIN 8 0.0009
399 SOMNOLENCE 183 0.0009
400 DERMATITIS 19 0.0009
401 OCULAR HYPERAEMIA 43 0.0009
402 HYPOTONIA 9 0.0009
403 RESPIRATORY RATE INCREASED 8 0.0009
404 STEVENS-JOHNSON SYNDROME 20 0.0009
405 PELVIC FRACTURE 7 0.0009
406 PNEUMONIA 291 0.0009
407 URINARY TRACT INFECTION 153 0.0009
408 INJECTION SITE URTICARIA 22 0.0009
409 FOOT FRACTURE 17 0.0009
410 AFFECTIVE DISORDER 7 0.0009
411 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 160 0.0009
412 FURUNCLE 7 0.0009
413 TRICUSPID VALVE INCOMPETENCE 7 0.0009
414 ALANINE AMINOTRANSFERASE INCREASED 54 0.0009
415 CYSTITIS 28 0.0009
416 ABSCESS 14 0.0009
417 EYE MOVEMENT DISORDER 6 0.0009
418 SWELLING 82 0.0009
419 DYSPHONIA 51 0.0009
420 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
421 RESPIRATORY DISORDER 26 0.0009
422 ANAPHYLACTIC REACTION 48 0.0009
423 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
424 PERICARDIAL EFFUSION 20 0.0009
425 RASH 376 0.0009
426 HOT FLUSH 65 0.0009
427 FORMICATION 6 0.0009
428 DEPRESSION 196 0.0009
429 HYPOPHAGIA 22 0.0009
430 DYSPNOEA 487 0.0009
431 COORDINATION ABNORMAL 12 0.0009
432 DISABILITY 17 0.0009
433 DECUBITUS ULCER 7 0.0009
434 HEPATIC STEATOSIS 16 0.0009
435 HEART RATE INCREASED 85 0.0009
436 ERYTHEMA MULTIFORME 8 0.0009
437 RASH MACULO-PAPULAR 19 0.0009
438 WEIGHT DECREASED 238 0.0009
439 CONTUSION 82 0.0009
440 EYE DISORDER 28 0.0009
441 INCONTINENCE 9 0.0009
442 PHOTOPHOBIA 16 0.0008
443 RASH PAPULAR 19 0.0008
444 COVID-19 PNEUMONIA 10 0.0008
445 HAND FRACTURE 6 0.0008
446 FULL BLOOD COUNT DECREASED 17 0.0008
447 BLOOD URINE PRESENT 16 0.0008
448 CHROMATURIA 19 0.0008
449 NEUROPATHY PERIPHERAL 80 0.0008
450 FEELING JITTERY 16 0.0008
451 TASTE DISORDER 17 0.0008
452 FATIGUE 652 0.0008
453 HYPERSOMNIA 24 0.0008
454 CONSTIPATION 182 0.0008
455 WRIST FRACTURE 10 0.0008
456 HAEMODIALYSIS 7 0.0008
457 HEADACHE 522 0.0008
458 ACUTE RESPIRATORY FAILURE 16 0.0008
459 CANDIDA INFECTION 14 0.0008
460 WOUND 23 0.0008
461 CATARACT 49 0.0008
462 MAJOR DEPRESSION 6 0.0008
463 CHOKING 16 0.0008
464 QUALITY OF LIFE DECREASED 11 0.0008
465 RESTLESSNESS 30 0.0008
466 HYPERSENSITIVITY 152 0.0008
467 SCAR 14 0.0008
468 EPISTAXIS 61 0.0008
469 VITREOUS FLOATERS 8 0.0008
470 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
471 FOOT DEFORMITY 9 0.0008
472 ABDOMINAL PAIN UPPER 167 0.0008
473 ABDOMINAL DISCOMFORT 136 0.0008
474 EXPOSURE VIA SKIN CONTACT 21 0.0008
475 SKIN DISORDER 27 0.0008
476 TOOTH DISORDER 18 0.0008
477 HYSTERECTOMY 7 0.0008
478 KNEE ARTHROPLASTY 17 0.0008
479 PULMONARY MASS 12 0.0008
480 UPPER LIMB FRACTURE 16 0.0008
481 BLOOD CALCIUM DECREASED 9 0.0008
482 DEVICE USE ISSUE 14 0.0008
483 EYE IRRITATION 46 0.0008
484 EOSINOPHILIA 14 0.0008
485 PANIC ATTACK 29 0.0008
486 COLD SWEAT 14 0.0008
487 DIVERTICULITIS 22 0.0008
488 FEELING ABNORMAL 190 0.0008
489 LIVER FUNCTION TEST INCREASED 17 0.0008
490 ORAL DISCOMFORT 11 0.0008
491 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
492 OSTEOPENIA 12 0.0008
493 VAGINAL DISCHARGE 8 0.0008
494 FALL 262 0.0008
495 INCREASED APPETITE 15 0.0008
496 SLUGGISHNESS 8 0.0008
497 BODY TEMPERATURE INCREASED 16 0.0008
498 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
499 FEELING HOT 48 0.0008
500 PROCEDURAL COMPLICATION 6 0.0008
501 LETHARGY 45 0.0008
502 NEUTROPHIL COUNT INCREASED 8 0.0008
503 JAUNDICE 21 0.0008
504 NIGHTMARE 27 0.0008
505 THERAPEUTIC RESPONSE UNEXPECTED 35 0.0008
506 PRODUCT PREPARATION ERROR 16 0.0008
507 THYROID DISORDER 12 0.0008
508 HELICOBACTER INFECTION 8 0.0008
509 NIGHT SWEATS 25 0.0008
510 CELLULITIS 39 0.0008
511 ARTHROPATHY 43 0.0008
512 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
513 DEHYDRATION 103 0.0008
514 DIARRHOEA 498 0.0008
515 HAEMORRHOIDS 15 0.0008
516 BLOOD PRESSURE DECREASED 51 0.0008
517 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
518 DRY MOUTH 62 0.0008
519 FOLLICULITIS 8 0.0008
520 CHOLELITHIASIS 25 0.0008
521 ANHEDONIA 20 0.0008
522 PYREXIA 263 0.0008
523 GASTROINTESTINAL DISORDER 68 0.0008
524 HEAD INJURY 24 0.0008
525 GRAND MAL CONVULSION 7 0.0008
526 ABNORMAL BEHAVIOUR 30 0.0008
527 JOINT DISLOCATION 8 0.0008
528 BLOOD ALBUMIN DECREASED 6 0.0008
529 PRODUCT USE IN UNAPPROVED INDICATION 187 0.0008
530 BLOOD PRESSURE ABNORMAL 15 0.0008
531 TREMOR 125 0.0008
532 HEPATIC ENZYME INCREASED 51 0.0007
533 ANGIOEDEMA 33 0.0007
534 ABORTION INDUCED 7 0.0007
535 THERAPY INTERRUPTED 53 0.0007
536 LOSS OF CONSCIOUSNESS 95 0.0007
537 MUSCLE DISORDER 6 0.0007
538 ANGER 25 0.0007
539 OEDEMA PERIPHERAL 90 0.0007
540 ABDOMINAL DISTENSION 77 0.0007
541 INFLAMMATION 38 0.0007
542 MEMORY IMPAIRMENT 101 0.0007
543 CHILLS 86 0.0007
544 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
545 ABNORMAL FAECES 6 0.0007
546 ESCHERICHIA INFECTION 6 0.0007
547 OSTEOPOROSIS 30 0.0007
548 APHASIA 22 0.0007
549 WEIGHT INCREASED 163 0.0007
550 DIZZINESS 363 0.0007
551 DYSPHAGIA 69 0.0007
552 MUSCLE SPASMS 133 0.0007
553 DENTAL CARIES 8 0.0007
554 BACK PAIN 168 0.0007
555 DISTURBANCE IN ATTENTION 39 0.0007
556 GASTRITIS 19 0.0007
557 HYPERHIDROSIS 93 0.0007
558 DYSTONIA 14 0.0007
559 ARTHRALGIA 300 0.0007
560 LIP SWELLING 24 0.0007
561 CONDITION AGGRAVATED 219 0.0007
562 SKIN DISCOLOURATION 33 0.0007
563 TOOTHACHE 13 0.0007
564 NAUSEA 568 0.0007
565 LIVE BIRTH 6 0.0007
566 GLOSSODYNIA 16 0.0007
567 DEVICE RELATED INFECTION 11 0.0007
568 RENAL TUBULAR NECROSIS 7 0.0007
569 ASTHENIA 268 0.0007
570 HEPATOMEGALY 7 0.0007
571 SENSATION OF FOREIGN BODY 6 0.0007
572 THERAPY CHANGE 7 0.0007
573 CHRONIC KIDNEY DISEASE 54 0.0007
574 ANXIETY 201 0.0007
575 HAEMATOCRIT DECREASED 14 0.0007
576 BASAL CELL CARCINOMA 11 0.0007
577 INJECTION SITE SWELLING 54 0.0007
578 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
579 INJECTION SITE PRURITUS 47 0.0007
580 INTERNAL HAEMORRHAGE 8 0.0007
581 DEPRESSED MOOD 37 0.0007
582 SALIVARY HYPERSECRETION 7 0.0007
583 RED BLOOD CELL COUNT DECREASED 20 0.0007
584 SUICIDAL IDEATION 64 0.0007
585 ANOREXIA 9 0.0007
586 DECREASED APPETITE 162 0.0007
587 DIPLOPIA 18 0.0007
588 THERAPEUTIC RESPONSE DECREASED 42 0.0007
589 SKIN LESION 19 0.0007
590 INFLUENZA LIKE ILLNESS 57 0.0007
591 PULMONARY OEDEMA 31 0.0007
592 FAECES DISCOLOURED 15 0.0007
593 CHEST PAIN 128 0.0007
594 THERAPY NON-RESPONDER 31 0.0007
595 HYPOKINESIA 10 0.0007
596 HAND DEFORMITY 9 0.0007
597 ERYTHEMA 141 0.0007
598 NAIL DISORDER 6 0.0007
599 SYNCOPE 68 0.0007
600 LUNG INFILTRATION 6 0.0007
601 LABORATORY TEST ABNORMAL 20 0.0007
602 LIVER DISORDER 30 0.0007
603 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
604 SWELLING FACE 44 0.0007
605 GLAUCOMA 13 0.0007
606 BACTERAEMIA 8 0.0007
607 CHOLECYSTITIS 8 0.0007
608 FLATULENCE 38 0.0007
609 ACCIDENT 8 0.0007
610 MYOSITIS 6 0.0007
611 INJECTION SITE REACTION 46 0.0007
612 FREQUENT BOWEL MOVEMENTS 18 0.0007
613 PHOTOSENSITIVITY REACTION 11 0.0007
614 PALPITATIONS 78 0.0007
615 INSOMNIA 177 0.0007
616 HEART RATE IRREGULAR 15 0.0007
617 PAIN IN EXTREMITY 195 0.0007
618 DYSPEPSIA 65 0.0007
619 AGGRESSION 33 0.0007
620 PAIN 405 0.0007
621 MOOD SWINGS 21 0.0007
622 EXOSTOSIS 6 0.0007
623 BLOOD UREA INCREASED 11 0.0007
624 DEVICE FAILURE 10 0.0007
625 PHARMACEUTICAL PRODUCT COMPLAINT 17 0.0007
626 HIP ARTHROPLASTY 10 0.0007
627 RETINAL DETACHMENT 6 0.0007
628 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
629 HALLUCINATION 49 0.0006
630 LYMPHADENOPATHY 23 0.0006
631 SPEECH DISORDER 34 0.0006
632 BALANCE DISORDER 56 0.0006
633 BLOOD PRESSURE INCREASED 99 0.0006
634 MUSCULOSKELETAL CHEST PAIN 10 0.0006
635 HUNGER 9 0.0006
636 CIRCULATORY COLLAPSE 11 0.0006
637 CYST 8 0.0006
638 MASS 9 0.0006
639 DIARRHOEA HAEMORRHAGIC 6 0.0006
640 AGEUSIA 16 0.0006
641 PEMPHIGUS 8 0.0006
642 WOUND INFECTION 7 0.0006
643 ASPIRATION 7 0.0006
644 DERMATITIS ALLERGIC 8 0.0006
645 INJECTION SITE WARMTH 13 0.0006
646 SEIZURE 73 0.0006
647 EYE INFLAMMATION 6 0.0006
648 INJECTION SITE IRRITATION 8 0.0006
649 HYPOTENSION 126 0.0006
650 HYPOAESTHESIA 94 0.0006
651 SUICIDE ATTEMPT 38 0.0006
652 ATRIAL FIBRILLATION 61 0.0006
653 VOMITING 294 0.0006
654 LOWER LIMB FRACTURE 12 0.0006
655 VERTIGO 38 0.0006
656 SENSORY DISTURBANCE 10 0.0006
657 BLOOD CHOLESTEROL INCREASED 29 0.0006
658 GAIT DISTURBANCE 119 0.0006
659 HEAD DISCOMFORT 11 0.0006
660 HERNIA 12 0.0006
661 WITHDRAWAL SYNDROME 26 0.0006
662 MITRAL VALVE INCOMPETENCE 7 0.0006
663 HYPERTENSION 131 0.0006
664 MUSCLE TIGHTNESS 10 0.0006
665 MUSCULAR WEAKNESS 70 0.0006
666 BLOOD POTASSIUM INCREASED 10 0.0006
667 BONE PAIN 36 0.0006
668 MYALGIA 104 0.0006
669 JOINT INJURY 13 0.0006
670 UNEVALUABLE EVENT 46 0.0006
671 URINARY INCONTINENCE 18 0.0006
672 PRODUCT USE ISSUE 114 0.0006
673 VENTRICULAR TACHYCARDIA 10 0.0006
674 JOINT SWELLING 73 0.0006
675 MALAISE 265 0.0006
676 IMMUNODEFICIENCY 9 0.0006
677 PNEUMONIA ASPIRATION 15 0.0006
678 VISION BLURRED 82 0.0006
679 JOINT RANGE OF MOTION DECREASED 8 0.0006
680 TYPE 2 DIABETES MELLITUS 20 0.0006
681 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
682 EYELID PTOSIS 6 0.0006
683 BACTERIAL INFECTION 11 0.0006
684 RENAL FAILURE ACUTE 25 0.0006
685 PNEUMONITIS 16 0.0006
686 INJECTION SITE RASH 18 0.0006
687 HYPERLIPIDAEMIA 7 0.0006
688 EUPHORIC MOOD 6 0.0006
689 NEEDLE ISSUE 17 0.0006
690 PERIPHERAL COLDNESS 8 0.0006
691 SKIN ULCER 15 0.0006
692 HAEMATOCHEZIA 32 0.0006
693 PANCREATITIS ACUTE 13 0.0006
694 MENTAL STATUS CHANGES 16 0.0006
695 ABDOMINAL PAIN 134 0.0006
696 HERPES ZOSTER 33 0.0006
697 DEAFNESS 15 0.0006
698 PULMONARY FIBROSIS 11 0.0006
699 CHOLESTASIS 11 0.0006
700 CARDIAC FAILURE CONGESTIVE 46 0.0006
701 SEROTONIN SYNDROME 11 0.0006
702 PARAESTHESIA 90 0.0006
703 JOINT STIFFNESS 15 0.0006
704 MUSCULOSKELETAL STIFFNESS 50 0.0006
705 INJECTION SITE DISCOMFORT 6 0.0006
706 MUSCLE SPASTICITY 7 0.0006
707 SUDDEN DEATH 6 0.0006
708 TREATMENT NONCOMPLIANCE 31 0.0006
709 HOSPITALISATION 87 0.0006
710 IRRITABILITY 34 0.0006
711 MOVEMENT DISORDER 18 0.0006
712 PARALYSIS 8 0.0006
713 FEAR 15 0.0006
714 EPILEPSY 17 0.0006
715 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
716 LEUKOCYTOSIS 10 0.0006
717 SEPTIC SHOCK 24 0.0006
718 PRODUCT PRESCRIBING ISSUE 12 0.0006
719 CRYING 20 0.0005
720 PULMONARY THROMBOSIS 6 0.0005
721 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
722 SPINAL FRACTURE 11 0.0005
723 RESPIRATORY FAILURE 40 0.0005
724 THROMBOSIS 44 0.0005
725 ERECTILE DYSFUNCTION 14 0.0005
726 CARDIAC DISORDER 51 0.0005
727 SWOLLEN TONGUE 17 0.0005
728 ABNORMAL DREAMS 15 0.0005
729 FEEDING DISORDER 11 0.0005
730 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
731 RENAL FAILURE 72 0.0005
732 PSORIATIC ARTHROPATHY 22 0.0005
733 INJECTION SITE MASS 20 0.0005
734 TACHYCARDIA 48 0.0005
735 URINARY RETENTION 18 0.0005
736 DEEP VEIN THROMBOSIS 35 0.0005
737 AGRANULOCYTOSIS 10 0.0005
738 THINKING ABNORMAL 10 0.0005
739 NODULE 7 0.0005
740 MALNUTRITION 6 0.0005
741 BLOOD CREATININE INCREASED 35 0.0005
742 PRESYNCOPE 13 0.0005
743 BEDRIDDEN 7 0.0005
744 INJECTION SITE ERYTHEMA 66 0.0005
745 DYSARTHRIA 20 0.0005
746 HEMIPARESIS 9 0.0005
747 PULMONARY CONGESTION 7 0.0005
748 REBOUND EFFECT 6 0.0005
749 HYPOAESTHESIA ORAL 8 0.0005
750 LIVER INJURY 13 0.0005
751 ADVERSE REACTION 7 0.0005
752 IMPAIRED DRIVING ABILITY 6 0.0005
753 BURNING SENSATION 37 0.0005
754 CONFUSIONAL STATE 85 0.0005
755 WHITE BLOOD CELL COUNT DECREASED 57 0.0005
756 MICTURITION URGENCY 6 0.0005
757 MALIGNANT MELANOMA 7 0.0005
758 TINNITUS 24 0.0005
759 PARANOIA 9 0.0005
760 MOUTH ULCERATION 11 0.0005
761 BLOOD GLUCOSE DECREASED 25 0.0005
762 LYMPHOMA 8 0.0005
763 AGITATION 38 0.0005
764 PRESCRIBED OVERDOSE 10 0.0005
765 HYPOGLYCAEMIA 25 0.0005
766 RENAL DISORDER 24 0.0005
767 DELUSION 8 0.0005
768 IMPAIRED WORK ABILITY 11 0.0005
769 DYSSTASIA 15 0.0005
770 MOOD ALTERED 14 0.0005
771 PANCREATITIS 27 0.0005
772 GAIT INABILITY 17 0.0005
773 INJECTION SITE PAIN 156 0.0005
774 RESPIRATORY DISTRESS 14 0.0005
775 DEVICE DISLOCATION 22 0.0005
776 DISORIENTATION 20 0.0005
777 INTESTINAL OBSTRUCTION 19 0.0005
778 HYPOMAGNESAEMIA 7 0.0005
779 ROAD TRAFFIC ACCIDENT 21 0.0005
780 PREGNANCY 10 0.0005
781 BLOOD TEST ABNORMAL 7 0.0005
782 HAEMOGLOBIN DECREASED 51 0.0005
783 SEDATION 13 0.0005
784 PRODUCT PHYSICAL ISSUE 10 0.0005
785 MENTAL IMPAIRMENT 12 0.0005
786 PRODUCT ADMINISTRATION ERROR 10 0.0005
787 TRANSAMINASES INCREASED 11 0.0005
788 ADRENAL INSUFFICIENCY 6 0.0005
789 HEPATOTOXICITY 11 0.0005
790 PLEURAL EFFUSION 30 0.0005
791 DYSKINESIA 20 0.0005
792 RESPIRATORY DEPRESSION 6 0.0005
793 RECTAL HAEMORRHAGE 21 0.0005
794 ANAEMIA 93 0.0005
795 IMPAIRED HEALING 16 0.0005
796 DRUG INTOLERANCE 47 0.0005
797 TENDON RUPTURE 6 0.0005
798 DRUG INTERACTION 77 0.0005
799 GENERALISED OEDEMA 6 0.0005
800 RHEUMATOID ARTHRITIS 55 0.0005
801 HEART RATE DECREASED 17 0.0005
802 HYPERTHYROIDISM 7 0.0005
803 PRODUCT AVAILABILITY ISSUE 11 0.0005
804 MENTAL DISORDER 21 0.0005
805 HAIR COLOUR CHANGES 6 0.0005
806 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
807 INJECTION SITE DISCOLOURATION 6 0.0005
808 LEUKOPENIA 24 0.0005
809 PLATELET COUNT DECREASED 51 0.0005
810 NERVOUSNESS 25 0.0005
811 INTENTIONAL DRUG MISUSE 10 0.0005
812 PALLOR 13 0.0005
813 MUSCLE TWITCHING 11 0.0005
814 AMNESIA 31 0.0005
815 HALLUCINATION, VISUAL 10 0.0005
816 GASTRIC ULCER 9 0.0005
817 DIABETES MELLITUS 36 0.0005
818 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
819 FEELING COLD 13 0.0005
820 SEPSIS 52 0.0005
821 NEUTROPHIL COUNT DECREASED 19 0.0005
822 ERUCTATION 9 0.0005
823 BLOOD COUNT ABNORMAL 7 0.0005
824 DRUG DISPENSING ERROR 7 0.0005
825 DYSGEUSIA 34 0.0005
826 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
827 IMMUNE SYSTEM DISORDER 6 0.0005
828 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
829 MELAENA 10 0.0005
830 SARS-COV-2 TEST POSITIVE 6 0.0005
831 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
832 HAIR TEXTURE ABNORMAL 6 0.0004
833 CARDIAC ARREST 37 0.0004
834 PAIN OF SKIN 12 0.0004
835 SYNOVITIS 8 0.0004
836 PRODUCT TASTE ABNORMAL 6 0.0004
837 COMA 21 0.0004
838 HAEMORRHAGE 46 0.0004
839 ULCER 7 0.0004
840 INJECTION SITE BRUISING 35 0.0004
841 HIP FRACTURE 14 0.0004
842 DEVICE ISSUE 39 0.0004
843 DYSURIA 16 0.0004
844 HYPOKALAEMIA 20 0.0004
845 MOBILITY DECREASED 31 0.0004
846 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
847 HYPERKALAEMIA 15 0.0004
848 SKIN REACTION 6 0.0004
849 INJECTION SITE HAEMORRHAGE 34 0.0004
850 ALOPECIA 83 0.0004
851 COLITIS 16 0.0004
852 EMOTIONAL DISORDER 13 0.0004
853 MUSCULOSKELETAL DISORDER 8 0.0004
854 BLINDNESS 17 0.0004
855 PERICARDITIS 7 0.0004
856 BLOOD PRESSURE FLUCTUATION 10 0.0004
857 ANOSMIA 6 0.0004
858 STOMATITIS 25 0.0004
859 ADVERSE DRUG REACTION 37 0.0004
860 VISUAL IMPAIRMENT 51 0.0004
861 ILL-DEFINED DISORDER 25 0.0004
862 ASCITES 12 0.0004
863 HYPOTHYROIDISM 13 0.0004
864 CARDIOMYOPATHY 6 0.0004
865 INTENTIONAL OVERDOSE 26 0.0004
866 MULTI-ORGAN FAILURE 7 0.0004
867 PRESCRIBED UNDERDOSE 8 0.0004
868 INCORRECT DOSE ADMINISTERED 91 0.0004
869 INTERSTITIAL LUNG DISEASE 19 0.0004
870 DEVICE LEAKAGE 17 0.0004
871 PHARYNGEAL OEDEMA 6 0.0004
872 TENDONITIS 6 0.0004
873 PRODUCT SUBSTITUTION ISSUE 22 0.0004
874 CYANOSIS 6 0.0004
875 GASTRIC DISORDER 13 0.0004
876 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
877 DISEASE RECURRENCE 18 0.0004
878 LIVER FUNCTION TEST ABNORMAL 11 0.0004
879 MEDICATION ERROR 21 0.0004
880 HEPATIC FUNCTION ABNORMAL 14 0.0004
881 DEVICE USE ERROR 13 0.0004
882 PSYCHOTIC DISORDER 11 0.0004
883 MATERNAL EXPOSURE DURING PREGNANCY 33 0.0004
884 BLOOD BILIRUBIN INCREASED 10 0.0004
885 VAGINAL HAEMORRHAGE 16 0.0004
886 NEUTROPENIA 50 0.0004
887 MULTIPLE FRACTURES 6 0.0004
888 MANIA 6 0.0004
889 CARDIAC FAILURE 29 0.0004
890 EXPIRED PRODUCT ADMINISTERED 12 0.0004
891 PROCEDURAL PAIN 10 0.0004
892 PSORIASIS 47 0.0004
893 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
894 OFF LABEL USE 314 0.0004
895 DEMENTIA 10 0.0004
896 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
897 EMOTIONAL DISTRESS 43 0.0004
898 HAEMATEMESIS 9 0.0004
899 INTENTIONAL PRODUCT MISUSE 31 0.0004
900 NERVOUS SYSTEM DISORDER 11 0.0004
901 HAEMATURIA 12 0.0004
902 UNRESPONSIVE TO STIMULI 9 0.0003
903 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
904 PULMONARY EMBOLISM 33 0.0003
905 EXTRA DOSE ADMINISTERED 14 0.0003
906 ORTHOSTATIC HYPOTENSION 6 0.0003
907 MUSCULOSKELETAL PAIN 18 0.0003
908 INJURY 24 0.0003
909 MULTIPLE SCLEROSIS RELAPSE 23 0.0003
910 OSTEOMYELITIS 6 0.0003
911 END STAGE RENAL DISEASE 6 0.0003
912 NO ADVERSE EVENT 59 0.0003
913 HYPOACUSIS 14 0.0003
914 THROMBOCYTOPENIA 36 0.0003
915 PRODUCT DOSE OMISSION 21 0.0003
916 RENAL IMPAIRMENT 27 0.0003
917 DRUG INEFFECTIVE 423 0.0003
918 HEPATIC CIRRHOSIS 6 0.0003
919 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
920 ARRHYTHMIA 15 0.0003
921 DEVICE MALFUNCTION 22 0.0003
922 RHABDOMYOLYSIS 13 0.0003
923 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
924 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
925 DRUG WITHDRAWAL SYNDROME 27 0.0003
926 APPLICATION SITE ERYTHEMA 8 0.0003
927 ADVERSE EVENT 28 0.0003
928 HYPERGLYCAEMIA 11 0.0003
929 HYPONATRAEMIA 17 0.0003
930 BRADYCARDIA 16 0.0003
931 HEPATIC FAILURE 9 0.0003
932 INTENTIONAL SELF-INJURY 6 0.0003
933 SKIN BURNING SENSATION 21 0.0003
934 DELIRIUM 10 0.0003
935 DRUG-INDUCED LIVER INJURY 9 0.0003
936 NEOPLASM MALIGNANT 19 0.0003
937 ABASIA 7 0.0003
938 ANGINA PECTORIS 8 0.0003
939 COGNITIVE DISORDER 13 0.0003
940 CEREBROVASCULAR ACCIDENT 47 0.0003
941 ABDOMINAL PAIN LOWER 7 0.0003
942 C-REACTIVE PROTEIN INCREASED 10 0.0003
943 THERAPY CESSATION 14 0.0003
944 MULTIPLE SCLEROSIS 13 0.0003
945 ACCIDENTAL EXPOSURE TO PRODUCT 28 0.0003
946 ACUTE MYOCARDIAL INFARCTION 8 0.0003
947 BLOOD GLUCOSE INCREASED 51 0.0003
948 HAEMATOMA 7 0.0003
949 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
950 PREMATURE BABY 8 0.0003
951 BREAST CANCER FEMALE 7 0.0003
952 UNDERDOSE 19 0.0003
953 DRUG EFFECT DECREASED 14 0.0003
954 PLASMA CELL MYELOMA 10 0.0003
955 PANCYTOPENIA 14 0.0003
956 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
957 TARDIVE DYSKINESIA 7 0.0002
958 LACTIC ACIDOSIS 8 0.0002
959 OSTEONECROSIS 8 0.0002
960 PANCREATIC CARCINOMA 7 0.0002
961 ACUTE KIDNEY INJURY 37 0.0002
962 EXTRAPYRAMIDAL DISORDER 6 0.0002
963 VISUAL ACUITY REDUCED 8 0.0002
964 ACNE 18 0.0002
965 NEOPLASM PROGRESSION 8 0.0002
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
967 BONE DENSITY DECREASED 7 0.0002
968 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
970 DEATH 188 0.0002
971 PRODUCT QUALITY ISSUE 29 0.0002
972 DISEASE PROGRESSION 25 0.0002
973 FEBRILE NEUTROPENIA 14 0.0002
974 COLITIS ULCERATIVE 9 0.0002
975 MYOCARDIAL INFARCTION 34 0.0002
976 EXPOSURE DURING PREGNANCY 12 0.0002
977 COMPLETED SUICIDE 16 0.0002
978 CARDIO-RESPIRATORY ARREST 8 0.0002
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
980 BREAST CANCER 17 0.0002
981 SKIN IRRITATION 8 0.0002
982 DEVICE BREAKAGE 7 0.0002
983 LUNG NEOPLASM MALIGNANT 7 0.0002
984 CEREBRAL HAEMORRHAGE 6 0.0002
985 DRUG DOSE OMISSION 27 0.0002
986 OVERDOSE 35 0.0002
987 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
988 TREATMENT FAILURE 12 0.0001
989 PRODUCT STORAGE ERROR 12 0.0001
990 DEVICE DIFFICULT TO USE 9 0.0001
991 RENAL CANCER 6 0.0001
992 PROSTATE CANCER 9 0.0001
993 DRUG DEPENDENCE 17 0.0001
994 TOXICITY TO VARIOUS AGENTS 10 0.0001